ELECTROCORE INC (ECOR)

Company Profile

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. The company is headquartered in Rockaway, New Jersey and currently employs 62 full-time employees. The company went IPO on 2018-06-22. The company provides non-invasive vagus nerve stimulation (nVNS) technology platform. The company is focused on commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to general wellbeing and human performance in the United States and select overseas markets. nVNS is a platform bioelectronic technology that modulates neurotransmitters through its effects on both the peripheral and central nervous systems. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore device for the treatment of pain associated with each migraine headache and episodic cluster headache in adults, the preventive treatment of migraine headache and adjunctive use for the preventive treatment of cluster headache in adults, the acute and preventive treatment of migraine in adolescents and Paroxysmal Hemicrania, and Hemicrania Continua in adults.

Company Info

ELECTROCORE INC

200 Forge Way, Suite 205

Rockaway NEW JERSEY 07866

P: 19732900097

CEO: Daniel S. Goldberger

Employees: 62

Website: https://www.electrocore.com/